Condition
Malaria Recrudescence
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05287893Phase 1Completed
Pyronaridine in Healthy Adult Participants Infected With Blood Stage Malaria
NCT05958810Completed
TES of Artemether-lumefantrine for Pf in the Philippines in 2017-2018
NCT05958693Completed
TES of Artemether-lumefantrine for Pf in the Philippines in 2015
NCT04222088Completed
TES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014
Showing all 4 trials